Oral ezatiostat HCl (Telintra®, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with...

by Lyons, Roger M, Wilks, Sharon T, Young, Shelby, Brown, Gail L
Published 2011

Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG

by Zoghi, Behyar, Shaughnessy, Paul, Lyons, Roger M., Helmer, Richard, Bachier, Carlos, LeMaistre, C. Frederick
Published 2015

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic...

by Wang, Eunice S, Lyons, Roger M, Larson, Richard A, Gandhi, Sunil, Liu, Delong, Matei, Carmen, Scott, Bart, Hu, Kuolung, Yang, Allen S
Published 2012

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

by Raza, Azra, Galili, Naomi, Mulford, Deborah, Smith, Scott E, Brown, Gail L, Steensma, David P, Lyons, Roger M, Boccia, Ralph, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Mesa, Ruben A
Published 2012

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts

by Talpaz, Moshe, Paquette, Ronald, Afrin, Lawrence, Hamburg, Solomon I, Prchal, Josef T, Jamieson, Katarzyna, Terebelo, Howard R, Ortega, Gregory L, Lyons, Roger M, Tiu, Ramon V, Winton, Elliott F, Natrajan, Kavita, Odenike, Olatoyosi, Claxton, David, Peng, Wei, O’Neill, Peter, Erickson-Viitanen, Susan, Leopold, Lance, Sandor, Victor, Levy, Richard S, Kantarjian, Hagop M, Verstovsek, Srdan
Published 2013